ASTS
AST SpaceMobile, Inc.
ASTS lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to grow, though they disagree widely on how much.
PXLW
Pixelworks, Inc.
There isn't enough reported data to score PXLW yet.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
PXLW Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Healthy | |
| Unavailable | |
| Unavailable |
PXLW's profitability is currently healthy, but its revenue is under pressure. There isn't enough data to rate its cash flow and balance sheet.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
PXLW PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 0.5x | $5.88 | +1% |
| Current | 0.5x | $5.82 | — |
| Fair | 0.6x | $7.08 | +22% |
| Expensive | 0.7x | $7.37 | +27% |
Historical ranges are pointers, not guarantees.
PXLW's PE is 0.5x, but its earnings don't support one, so it isn't a reliable read right now.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
PXLW Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong decline | |
| -- | |
| Limited | |
| High |
Analysts expect PXLW's losses to shrink, with revenue declining.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
PXLW Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | $10.91 | +$15.63 |
| Q2 2026 | $10.56 | +$16.15 |
| Q1 2026 | $9.73 | +$16.09 |
| Q4 2025 | -$4.29 | +$1.59 |
| Q3 2025 | -$4.72 | +$0.92 |
| Q2 2025 | -$5.59 | -$0.19 |
| Q1 2025 | -$6.36 | -$1.68 |
| Q4 2024 | -$5.88 | -$0.24 |
PXLW has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS has the edge over PXLW on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS has the edge over PXLW on profitability, with a higher operating margin.
PXLW Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $378K | -96% |
| Q2 2026 | $64K | -99% |
| Q1 2026 | $446K | -94% |
| Q3 2025 | $8.8M | -7.9% |
| Q2 2025 | $8.3M | -3.3% |
| Q1 2025 | $7.1M | -56% |
| Q4 2024 | $9.1M | -55% |
| Q3 2024 | $9.5M | -41% |
PXLW's revenue has slid since its 2023 peak: $378,000 last quarter, down 96% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -909% | -845 points |
| Q2 2026 | -5256% | -5168 points |
| Q1 2026 | -1101% | -987 points |
| Q3 2025 | -64% | +27 points |
| Q2 2025 | -89% | +37 points |
| Q1 2025 | -114% | -80 points |
| Q4 2024 | -71% | -51 points |
| Q3 2024 | -91% | -43 points |
PXLW's operating margin was −909% last quarter, down 820 points from the same quarter a year ago, near the bottom of its range since 2019.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
PXLW Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.8M | +$1.2M |
| Q2 2026 | -$1.7M | +$3M |
| Q1 2026 | -$4.7M | +$2M |
| Q4 2025 | -$6.5M | -$809K |
| Q3 2025 | -$3M | +$5.6M |
| Q2 2025 | -$4.8M | +$3.3M |
| Q1 2025 | -$6.7M | -$5.5M |
| Q4 2024 | -$5.7M | -$3.5M |
PXLW has the edge over ASTS on cash flow, with more consistent year-over-year improvement.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has the edge over PXLW on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
PXLW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.8% | -238K shares |
| 1 year | +11% | +616K shares |
| 3 years | +29% | +1.4M shares |
| 5 years | +38% | +1.7M shares |
| Available history | +92% | +2.9M shares |
PXLW has 6M diluted shares, up 11% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.2M |
| Q4 2025 | — |
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PXLW Net Leverage
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
PXLW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 46.0 | Neutral |
| Stochastic | 16.4 | Oversold |
PXLW's weekly RSI is 46 (neutral) and its Stochastic is 16 (oversold).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
PXLW PE vs Technology Sector
| Metric | PXLW | Sector median | Relative |
|---|---|---|---|
| PE | 0.5x | 28x | 98% below |
| PE % | 15 | 35 | 20 pts below |
PXLW is trading at 0.5x earnings, a 98% discount to the Technology sector's median of 28x, though its earnings don't support one.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has the edge over PXLW on trend strength, trading above more of its moving averages.
PXLW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $5.83 | 0.2% below |
| 20 week MA | $6.24 | 6.7% below |
| 50 week MA | $6.22 | 6.4% below |
| 100 week MA | $7.30 | 20% below |
| 200 week MA | $12.1 | 52% below |
PXLW is in a downtrend: it's below all five of its weekly moving averages, and 52% below its 200-week average.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
PXLW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $40.7 | $33.5 | -18% |
| 2021 | $33.5 | $59.2 | +77% |
| 2022 | $59.2 | $16.6 | -72% |
| 2023 | $16.6 | $15.7 | -5.1% |
| 2024 | $15.7 | $8.75 | -44% |
| 2025 | $8.75 | $6.79 | -22% |
| 2026 YTD | $6.79 | $5.82 | -14% |
PXLW has the edge over ASTS on returns for 2026, with the stronger performance.